Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elmer Maurits

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Chembiochem : a European Journal of Chemical Biology|June 30, 2020
Structure-Based Design of Fluorogenic Substrates Selective for Human Proteasome SubunitsElmer Maurits, Christian G Degeling, Alexei F Kisselev, et al.
British Journal of Pharmacology|October 17, 2017
Amelioration of autoimmunity with an inhibitor selectively targeting all active centres of the immunoproteasomeMichael Basler, Elmer Maurits, Gerjan de Bruin, et al.
Bioorganic & Medicinal Chemistry|July 3, 2014
In situ formation of H2O2 for P450 peroxygenasesCaroline E Paul, Ekaterina Churakova, Elmer Maurits, et al.
Cells|March 10, 2022
Immunoproteasome Activity in Chronic Lymphocytic Leukemia as a Target of the Immunoproteasome-Selective InhibitorsAndrej Besse, Marianne Kraus, Max Mendez-Lopez, et al.
Chemical Science|June 7, 2021
Synthetic methodology towards allylic <i>trans</i>-cyclooctene-ethers enables modification of carbohydrates: bioorthogonal manipulation of the <i>lac</i> repressorMark A R de Geus, G J Mirjam Groenewold, Elmer Maurits, et al.
Cells|November 27, 2021
High Immunoproteasome Activity and sXBP1 in Pediatric Precursor B-ALL Predicts Sensitivity towards Proteasome InhibitorsLenka Besse, Andrej Besse, Marianne Kraus, et al.
European Journal of Immunology|March 8, 2024
Katharina Inholz, Janet L Anderl, Moritz Klawitter, et al.
Journal of Medicinal Chemistry|January 8, 2026
Structure-Based Design of Pan-Selective Peptide Epoxyketones for the Three Human Immunoproteasome Active SitesPatrick M Dekker, Eva M Huber, Elmer Maurits, et al.
Cell Chemical Biology|January 8, 2019
Proteasome Inhibition in Multiple Myeloma: Head-to-Head Comparison of Currently Available Proteasome InhibitorsAndrej Besse, Lenka Besse, Marianne Kraus, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 6, 2018
Fast and pH-Independent Elimination of trans-Cyclooctene by Using Aminoethyl-Functionalized TetrazinesAlexi J C Sarris, Thomas Hansen, Mark A R de Geus, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Chembiochem : a European Journal of Chemical Biology|June 30, 2020
Structure-Based Design of Fluorogenic Substrates Selective for Human Proteasome SubunitsElmer Maurits, Christian G Degeling, Alexei F Kisselev, et al.
British Journal of Pharmacology|October 17, 2017
Amelioration of autoimmunity with an inhibitor selectively targeting all active centres of the immunoproteasomeMichael Basler, Elmer Maurits, Gerjan de Bruin, et al.
Bioorganic & Medicinal Chemistry|July 3, 2014
In situ formation of H2O2 for P450 peroxygenasesCaroline E Paul, Ekaterina Churakova, Elmer Maurits, et al.
Cells|March 10, 2022
Immunoproteasome Activity in Chronic Lymphocytic Leukemia as a Target of the Immunoproteasome-Selective InhibitorsAndrej Besse, Marianne Kraus, Max Mendez-Lopez, et al.
Chemical Science|June 7, 2021
Synthetic methodology towards allylic <i>trans</i>-cyclooctene-ethers enables modification of carbohydrates: bioorthogonal manipulation of the <i>lac</i> repressorMark A R de Geus, G J Mirjam Groenewold, Elmer Maurits, et al.
Cells|November 27, 2021
High Immunoproteasome Activity and sXBP1 in Pediatric Precursor B-ALL Predicts Sensitivity towards Proteasome InhibitorsLenka Besse, Andrej Besse, Marianne Kraus, et al.
European Journal of Immunology|March 8, 2024
Katharina Inholz, Janet L Anderl, Moritz Klawitter, et al.
Journal of Medicinal Chemistry|January 8, 2026
Structure-Based Design of Pan-Selective Peptide Epoxyketones for the Three Human Immunoproteasome Active SitesPatrick M Dekker, Eva M Huber, Elmer Maurits, et al.
Cell Chemical Biology|January 8, 2019
Proteasome Inhibition in Multiple Myeloma: Head-to-Head Comparison of Currently Available Proteasome InhibitorsAndrej Besse, Lenka Besse, Marianne Kraus, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 6, 2018
Fast and pH-Independent Elimination of trans-Cyclooctene by Using Aminoethyl-Functionalized TetrazinesAlexi J C Sarris, Thomas Hansen, Mark A R de Geus, et al.
Pageof 2